Gilead Sciences Inc.’s stock fell, then reversed those losses in after-hours trade Thursday, after the drug company posted weaker-than-expected second-quarter profit and tweaked its guidance. Back To ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback